Agent for treating vertebral artery of cervical spondylosis

A technology for formulating prescriptions and cervical spondylosis, which is applied in the fields of medical formulas, plant raw materials, cardiovascular system diseases, etc., and can solve problems such as toxic side effects, long treatment time, and unsatisfactory CSA effects

Inactive Publication Date: 2018-04-20
孙其斌
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, although there are many drugs for the treatment of this disease, most of them are western medicines. These western medicines have certain effects, but the phenomenon of toxic and side effects is relatively serious, and they are easy to repeat. In addition, western medicine generally has high treatment costs and long treatment time. , and the curative effect is not ideal
Therefore, the effect of existing drugs in the treatment of CSA is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Embodiment 1: This embodiment discloses a medicinal prescription for treating vertebral artery type cervical spondylosis, and its raw material components and weight percentages are: 12 parts of Chinese herbal medicine, 15 parts of lentils, 15 parts of Magnolia officinalis, 30 parts of Rhizoma Chuanxiong, and 10 parts of Angelica sinensis , 15 parts of gastrodia elata, 15 parts of kudzu root, 5 parts of rhubarb, 6 parts of licorice. The medicine taking method of the present invention: take decoction orally, take 3 times a day, one dose each time, 6-10 days is a course of treatment. The cure rate for 100 patients was 78%, 12% had a significant curative effect, and 10% had a certain curative effect.

Embodiment 2

[0016] Embodiment 2: This embodiment discloses a medicinal prescription for treating vertebral artery type cervical spondylosis, and its raw material components and weight percentages are: 15 parts of Chinese herbal medicine, 15 parts of lentils, 10 parts of Magnolia officinalis, 20 parts of Rhizoma Chuanxiong, and 10 parts of Angelica sinensis , 10 parts of gastrodia elata, 15 parts of kudzu root, 5 parts of rhubarb, and 6 parts of licorice. The medicine taking method of the present invention: take decoction orally, take 3 times a day, one dose each time, 6-10 days is a course of treatment. The cure rate of 100 patients is 75%, 10% have a significant curative effect, and 15% have a certain curative effect.

Embodiment 3

[0017] Embodiment 3: This embodiment discloses a medicinal prescription for treating vertebral artery type cervical spondylosis, and its raw material components and weight percentages are: 12 parts of Chinese herbal medicine, 15 parts of lentils, 10 parts of Magnolia officinalis, 15 parts of Rhizoma Chuanxiong, and 15 parts of Angelica sinensis , 10 parts of gastrodia elata, 20 parts of kudzu root, 5 parts of rhubarb, and 6 parts of licorice. The medicine taking method of the present invention: take decoction orally, take 3 times a day, one dose each time, 6-10 days is a course of treatment. The cure rate for 100 patients was 89%, 6% had a significant curative effect, and 5% had a certain curative effect.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Touqing prescription for treating cervical spondylosis, which is an oral medicine prescription made from pure natural plants such as fenugreek, lentils, magnolia officinalis, chuanxiong, angelica, gastrodia elata, kudzu root, rhubarb and licorice as raw materials through rational formulation. It combines the unique effects of various herbs, so that it has the effects of promoting clearness and reducing turbidity, aroma and stomach refreshing, promoting blood circulation and removing blood stasis. It is not only beneficial to relieve the clinical symptoms of patients, but also can improve local blood circulation, expand the vertebral basilar artery blood vessels, thereby improving the symptoms of vertebral basilar artery insufficiency in patients with cervical spondylosis. The clinical application is extensive, and it is safe and has no side effects, so it is an ideal drug prescription for treating cervical spondylosis.

Description

technical field [0001] The invention relates to an oral medicine prescription for treating vertebral artery type cervical spondylosis, in particular to a Chinese patent medicine prepared from Chinese herbal medicines. Background technique [0002] Cervical spondylosis of vertebral artery type (CSA) is a common type of cervical spondylosis. It occurs clinically in middle-aged and elderly people, and it is increasing year by year and showing a trend of younger age. During the onset of CSA, symptoms such as headache, dizziness, tinnitus and deafness, visual impairment, nausea, and vomiting are often manifested, which seriously affect the patient's health and quality of life. Modern medicine believes that CSA is caused by cervical vertebral hyperostosis, intervertebral joint instability, abnormal cervical curvature and many other factors that cause the vertebral artery to be stimulated, stretched, compressed, or stimulate the sympathetic plexus around the vertebral artery, causi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8988A61P19/08A61P9/00A61P9/10
CPCA61K36/53A61K36/232A61K36/236A61K36/48A61K36/484A61K36/488A61K36/575A61K36/708A61K36/8988A61K2300/00
Inventor 孙其斌
Owner 孙其斌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap